Harold J. DeMonaco

988 total citations · 1 hit paper
16 papers, 675 citations indexed

About

Harold J. DeMonaco is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Harold J. DeMonaco has authored 16 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Pharmacology and 4 papers in Economics and Econometrics. Recurrent topics in Harold J. DeMonaco's work include Pharmaceutical Economics and Policy (4 papers), Pharmaceutical industry and healthcare (3 papers) and Pharmaceutical studies and practices (3 papers). Harold J. DeMonaco is often cited by papers focused on Pharmaceutical Economics and Policy (4 papers), Pharmaceutical industry and healthcare (3 papers) and Pharmaceutical studies and practices (3 papers). Harold J. DeMonaco collaborates with scholars based in United States, Netherlands and Denmark. Harold J. DeMonaco's co-authors include Jeffrey S. Cooper, Glenn Laffel, Robert K. Hallisey, David W. Bates, Eric von Hippel, L S Friedman, Sara Kirkham, James M. Richter, Eric A. von Hippel and Jeroen P.J. de Jong and has published in prestigious journals such as Neurology, PLoS Medicine and American Journal of Health-System Pharmacy.

In The Last Decade

Harold J. DeMonaco

16 papers receiving 600 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systems analysis of adverse drug events. ADE Prevention Study Group.

1995 495 citations David W. Bates, Jeffrey S. Cooper et al. PubMed profile →

Peers

Harold J. DeMonaco

EMS

GG

HIM

PPCH

SURGE

Thomas Moniz United States

John P. Santell United States

Rianne J. Zaal Netherlands

L L Leape United States

Tonushree Jaggi United States

William N. Kelly United States

Lisa Pizziferri United States

Nidhi Shah United States

William Churchill United States

Monica M. Horvath United States

Thomas Moniz United States

Harold J. DeMonaco

322 ×1.0

EMS

241 ×0.9

GG

224 ×1.4

HIM

48 ×0.6

PPCH

112 ×1.4

SURGE

Citations per year, relative to Harold J. DeMonaco Harold J. DeMonaco (= 1×) peers Thomas Moniz

Countries citing papers authored by Harold J. DeMonaco

Since Specialization

Citations

This map shows the geographic impact of Harold J. DeMonaco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold J. DeMonaco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold J. DeMonaco more than expected).

Fields of papers citing papers by Harold J. DeMonaco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold J. DeMonaco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold J. DeMonaco. The network helps show where Harold J. DeMonaco may publish in the future.

Co-authorship network of co-authors of Harold J. DeMonaco

This figure shows the co-authorship network connecting the top 25 collaborators of Harold J. DeMonaco. A scholar is included among the top collaborators of Harold J. DeMonaco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold J. DeMonaco. Harold J. DeMonaco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

DeMonaco, Harold J., Pedro Oliveira, Andrew W. Torrance, Christiana von Hippel, & Eric A. von Hippel. (2019). When Patients Become Innovators. CBS Research Portal (Copenhagen Business School). 1 indexed citations

2.

DeMonaco, Harold J., et al.. (2018). Free Medical Innovation by Patients – No Producers Required. SSRN Electronic Journal. 4 indexed citations

3.

DeMonaco, Harold J., David J. Rosenman, & Eric A. von Hippel. (2017). Democratization of Human Clinical Research: How Peer Production is Changing the Research Paradigm. SSRN Electronic Journal. 1 indexed citations

4.

Hippel, Eric von, Harold J. DeMonaco, & Jeroen P.J. de Jong. (2016). Market failure in the diffusion of clinician-developed innovations: The case of off-label drug discoveries. Science and Public Policy. scw042–scw042. 27 indexed citations

5.

Hippel, Eric A. von & Harold J. DeMonaco. (2013). Market Failure in the Diffusion of User Innovations: The Case of 'Off-Label' Innovations by Medical Clinicians. SSRN Electronic Journal. 13 indexed citations

6.

DeMonaco, Harold J. & Greg Koski. (2007). Crossing the Great Divide: Adoption of New Technologies, Therapeutics and Diagnostics at Academic Medical Centers. 38(1). 31–38. 1 indexed citations

7.

DeMonaco, Harold J. & Eric von Hippel. (2007). Reducing Medical Costs and Improving Quality via Self-Management Tools. PLoS Medicine. 4(4). e104–e104. 6 indexed citations

8.

DeMonaco, Harold J., Ayfer H. Ali, & Eric A. von Hippel. (2005). The Major Role of Clinicians in the Discovery of Off-Label Drug Therapies. SSRN Electronic Journal. 7 indexed citations

9.

DeMonaco, Harold J., et al.. (1995). Economic Considerations in the Use of Neuromuscular Blocking Drugs. Survey of Anesthesiology. 39(2). 109???110–109???110. 2 indexed citations

10.

Bates, David W., et al.. (1995). Systems analysis of adverse drug events. ADE Prevention Study Group.. PubMed. 274(1). 35–43. 495 indexed citations breakdown →

11.

DeMonaco, Harold J., et al.. (1994). Economic considerations in the use of neuromuscular blocking drugs. Journal of Clinical Anesthesia. 6(5). 383–387. 15 indexed citations

12.

Friedman, L S, et al.. (1986). 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.. PubMed. 81(6). 412–8. 55 indexed citations

13.

DeMonaco, Harold J., et al.. (1986). Evaluation of a multiple-dose syringe pump system for intermittent i.v. drug delivery. American Journal of Health-System Pharmacy. 43(10). 2474–2479. 5 indexed citations

14.

DeMonaco, Harold J., et al.. (1983). Variability of Phenytoin Protein Binding in Epileptic Patients. Archives of Neurology. 40(8). 481–483. 14 indexed citations

15.

DeMonaco, Harold J. & Brian A. McGovern. (1983). Transient Asystole Associated with Amphotericin B Infusion. Drug Intelligence & Clinical Pharmacy. 17(7-8). 547–548. 15 indexed citations

16.

DeMonaco, Harold J., et al.. (1982). Protein binding of carbamazepine in epileptic patients. Neurology. 32(4). 415–415. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact